Trimedyne enters Holmium Lithotripsy market.IRVINE, Calif.--(BUSINESS WIRE)--Trimedyne Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :TMED TMED Transfusion Medicine ) Wednesday announced it has entered the lithotripsy (stone fragmentation) market with its Holmium holmium (hōl`mēəm) [Lat.,=Stockholm], metallic chemical element; symbol Ho; at. no. 67; at. wt. 164.9304; m.p. about 1,474°C;; b.p. about 2,425°C;; sp. gr. 8.78 at 25°C;; valence +3. "pulsed" Laser and an extremely small, flexible optical fiber, both of which are now available for sale. Lithotripsy procedures are performed on patients who develop stones, called urinary calculi Calculi (singular, calculus) Mineral deposits that can form a blockage in the urinary system. Mentioned in: Urinary Incontinence , in the urethra or bladder. These stones are of various colors. Currently, lasers creating light at particular wavelengths are used to fragment stones of a specific color. The very short, extremely high-powered pulses of energy generated by the Holmium Laser pulverize pul·ver·ize v. pul·ver·ized, pul·ver·iz·ing, pul·ver·iz·es v.tr. 1. To pound, crush, or grind to a powder or dust. 2. To demolish. v.intr. stones of virtually any color. Once fragmented, they may be passed in small pieces through the urinary system, avoiding the need for open surgery in many cases. Peter T. Hyde, president of Trimedyne stated, "Our OmniPulse-MAX(tm) Holmium Laser, in conjunction with a specially designed optical fiber, offers physicians a rapid, less expensive outpatient procedure for fragmenting stones in the urinary tract under direct visualization. "Our recent clearance from the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. for this purpose, as well as a license agreement to a U.S. Patent covering this procedure, will enable us to expand Trimedyne's product line in urology." Trimedyne is a leading manufacturer of "cold" and "thermal" lasers and proprietary delivery systems for minimally invasive applications in the urology, orthopedic, surgery and cardiovascular fields. CONTACT: Trimedyne James L. Kelly, 714/559-5300 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion